BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 16312857)

  • 1. Results of three polychemotherapy programs in non-Hodgkin's lymphomas.
    Konopka L; Pawelski S
    J Chemother; 1989 Jul; 1(4 Suppl):1259-62. PubMed ID: 16312857
    [No Abstract]   [Full Text] [Related]  

  • 2. CBVPM/AVBP versus HCOMLA chemotherapy in non-Hodgkin lymphoma patients.
    Pawelski S; Konopka L; Pakulska J; Gutkowska J
    Chemioterapia; 1987 Jun; 6(2 Suppl):716-9. PubMed ID: 2475265
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of medium and highly malignant non-Hodgkin's lymphoma with combined chemotherapy using methotrexate, adriamycin, cyclophosphamide, vincristine, prednisone and bleomycin (protocol MACOP-B)].
    Pittrová H; Koza V; Vozobulová V; Cetkovský P; Skopek P; Jungerová J; Cepelák V
    Vnitr Lek; 1989 Dec; 35(12):1177-82. PubMed ID: 2483776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stevens-Johnson syndrome associated with methotrexate treatment for non-Hodgkin's lymphoma.
    Cuthbert RJ; Craig JI; Ludlam CA
    Ulster Med J; 1993 Apr; 62(1):95-7. PubMed ID: 7685956
    [No Abstract]   [Full Text] [Related]  

  • 5. [M-BACOD in advanced case of non-Hodgkin's lymphoma].
    Itami J; Ogata H; Shimizu K; Nemoto K; Yasuda S; Yoshida H; Mikata A; Arimizu N
    Gan No Rinsho; 1990 Mar; 36(4):499-504. PubMed ID: 1690824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the stages of aggressive non-Hodgkin's lymphoma--a work in progress.
    Armitage JO
    N Engl J Med; 2005 Mar; 352(12):1250-2. PubMed ID: 15788502
    [No Abstract]   [Full Text] [Related]  

  • 7. [Malignant lymphomas. Preliminary report of the National Protocol of Antineoplastic Drugs].
    Gutiérrez J; Osorio G; García H; Vacarezza R; Cao C
    Rev Med Chil; 1991 Sep; 119(9):990-1000. PubMed ID: 1726958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary stage I-IIE non-Hodgkin's lymphoma of uterine cervix and upper vagina: evidence for a conservative approach in a study on three patients.
    Garavaglia E; Taccagni G; Montoli S; Panacci N; Ponzoni M; Frigerio L; Mangili G
    Gynecol Oncol; 2005 Apr; 97(1):214-8. PubMed ID: 15790461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The chemoradiation treatment of patients with aggressive non-Hodgkin's lymphomas in the III-IV stages of the disease].
    Sotnikov VM; Pan'shin GA; Pivnik AV; Grigor'eva MA
    Ter Arkh; 1992; 64(7):54-6. PubMed ID: 1440370
    [No Abstract]   [Full Text] [Related]  

  • 10. What constitutes "improved prognosis"?
    Canellos GP
    J Clin Oncol; 2008 Apr; 26(12):1913-4. PubMed ID: 18421041
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group.
    Vose JM; Anderson JR; Bierman PJ; Bast M; Weisenburger D; Chan WC; Bishop MR; Armitage JO
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):4-8. PubMed ID: 7521065
    [No Abstract]   [Full Text] [Related]  

  • 12. CHOP versus intensive regimens in non-Hodgkin's lymphoma.
    Longo DL; DeVita VT; Young RC
    N Engl J Med; 1993 Aug; 329(8):580-1; author reply 581-2. PubMed ID: 7687747
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment by the CHOP protocol in malignant non-Hodgkin lymphomas with high malignancy].
    Gociu M; Leahu S; Stoica I; Iofciulescu A; Berceanu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(1):47-51. PubMed ID: 2899347
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-hodgkins lymphoma.
    Mead G; Woodcock J; Young C
    Clin Evid; 2003 Jun; (9):1-21. PubMed ID: 12967352
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lactic acidosis in non-Hodgkin's lymphoma].
    Navigante AH; Chacón RD
    Medicina (B Aires); 1985; 45(6):667-9. PubMed ID: 2431249
    [No Abstract]   [Full Text] [Related]  

  • 16. [Vibrio cholerae can be encountered even at home].
    Sinisalo M; Oksanen K; Koivisto V; Vikberg V
    Duodecim; 1991; 107(22):1880-3. PubMed ID: 1285425
    [No Abstract]   [Full Text] [Related]  

  • 17. [Nutritional and defunctionalized jejunostomy in the chemotherapeutic treatment of gastric non-Hodgkin's lymphoma. Preliminary experience].
    Messinetti S; Martelli M; Giacomelli L; Brescia A; Miglietta AM; Pulcini A; Finizio R; Porcelli C
    Ann Ital Chir; 1993; 64(3):295-300. PubMed ID: 7509128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-Hodgkin's lymphomas: recent achievements and therapeutic perspectives].
    Bron D; Vandenheule B; Stryckmans P
    Rev Med Brux; 1985 Sep; 6(7):491-5. PubMed ID: 2417298
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chemotherapy of malignant lymphomas].
    Luporini G
    Radiol Med; 1976; 62(7-8):553-7. PubMed ID: 95671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomas.
    Gerhartz HH; Engelhard M; Brittinger G; Schlimok G; Thiel E; Huber C; Emmerich B; Schadek C; Brandmaier R; Stern AC
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):25-8. PubMed ID: 7528447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.